Merck-Eisai's kidney cancer drug combo meets one endpoint of late-stage study - Reuters

Reuters | Oct. 28, 2025, 5:57 p.m. | Original
Merck-Eisai's kidney cancer drug combo meets one endpoint of late-stage study Reuters
News by Acceswire on TradingView, 2025-10-28 - TradingView 'Battlefield' maker EA misses quarterly bookings estimates on uncertain gamer spend - Reuters